Eton Pharmaceuticals, Inc. - 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the 2022 Annual Meeting of Stockholders held on June 14, 2022, in Deer Park, Illinois. Eton Pharmaceuticals, Inc. is an emerging growth company incorporated in Delaware.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters.
Material Changes and Voting Results
Stockholders voted on two proposals at the Annual Meeting:
- Proposal 1: Election of Directors - Paul V. Maier was elected for a three-year term.
- For: 5,931,702
- Against: 403,998
- Abstain: 32,804
- Broker Non-Votes: 8,648,404
- Proposal 2: Ratification of Auditors - KMJ Corbin & Company LLP was ratified as the independent registered public accounting firm for the year ending December 31, 2022.
- For: 14,483,058
- Against: 496,263
- Abstain: 37,287
- Broker Non-Votes: 0
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Paul V. Maier has been elected to the Board of Directors for a three-year term.
- KMJ Corbin & Company LLP has been confirmed as the independent auditor for fiscal year 2022.
- A significant number of broker non-votes (8,648,404) were recorded for the director election, indicating shares held by brokers where voting instructions were not received.